Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Faisal Khurshid is an analyst at Leerink Partners. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/17/2025 | NRIX | Buy Now | Nurix Therapeutics | $13.66 | 17.13% | Faisal Khurshid32% | → $16 | Initiates | → Market Perform | Get Alert |
| 03/17/2025 | STTK | Buy Now | Shattuck Labs | $1.19 | 236.3% | Faisal Khurshid32% | → $4 | Initiates | → Outperform | Get Alert |
| 03/03/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.72 | 16.28% | Faisal Khurshid32% | $33 → $2 | Downgrade | Outperform → Market Perform | Get Alert |
| 02/18/2025 | ATYR | Buy Now | aTyr Pharma | $3.88 | 312.37% | Faisal Khurshid32% | → $16 | Initiates | → Outperform | Get Alert |
| 12/27/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 76.32% | Faisal Khurshid32% | $60 → $60 | Maintains | Outperform | Get Alert |
| 12/11/2024 | ANIP | Buy Now | ANI Pharmaceuticals | $64.22 | 24.57% | Faisal Khurshid32% | → $80 | Initiates | → Outperform | Get Alert |
| 11/04/2024 | ZURA | Buy Now | Zura Bio | $1.31 | 1045.04% | Faisal Khurshid32% | → $15 | Initiates | → Outperform | Get Alert |
| 09/09/2024 | TRVI | Buy Now | Trevi Therapeutics | $6.55 | 6.87% | Faisal Khurshid32% | → $7 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | PRTC | Buy Now | PureTech Health | $18.35 | 145.23% | Faisal Khurshid32% | → $45 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.72 | 1818.6% | Faisal Khurshid32% | → $33 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $1.50 | 233.33% | Faisal Khurshid32% | → $5 | Initiates | → Market Perform | Get Alert |
| 09/09/2024 | GLPG | Buy Now | Galapagos | $25.84 | -7.12% | Faisal Khurshid32% | → $24 | Initiates | → Market Perform | Get Alert |
| 09/09/2024 | GERN | Buy Now | Geron | $1.71 | 309.36% | Faisal Khurshid32% | → $7 | Initiates | → Outperform | Get Alert |
| 09/09/2024 | MNKD | Buy Now | MannKind | $5.21 | 53.55% | Faisal Khurshid32% | → $8 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | KYMR | Buy Now | Kymera Therapeutics | $34.03 | 76.32% | Faisal Khurshid32% | → $60 | Assumes | → Outperform | Get Alert |
| 09/09/2024 | IMUX | Buy Now | Immunic | $1.14 | 338.6% | Faisal Khurshid32% | → $5 | Assumes | → Outperform | Get Alert |
| 03/19/2024 | FUSN | Buy Now | Fusion Pharmaceuticals | — | — | Faisal Khurshid32% | $17 → $21 | Downgrade | Outperform → Market Perform | Get Alert |
| 03/21/2023 | RAIN | Buy Now | Rain Oncology | $1.95 | 464.1% | Faisal Khurshid32% | → $11 | Initiates | → Outperform | Get Alert |
